Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Susana Banerjee"'
Autor:
Helen Mackay, A. Casado Herraez, Bradley J. Monk, Nicoletta Colombo, Vicky Makker, Emeline Colomba, Lea Dutta, R Kristeleit, Michel Fabbro, David Miller, Alessandro D. Santin, Erin Jensen, Anne Floquet, Salvatore Antonio Pignata, Keiichi Fujiwara, M Orlando, Robert Orlowski, Richard T. Penson, Susana Banerjee, Domenica Lorusso
Publikováno v:
Annals of Oncology. 32:S729-S730
Autor:
I. Soumaoro, Bradley J. Monk, Anneke M. Westermann, Susana Banerjee, Domenica Lorusso, E. Gort, E Van Nieuwenhuysen, Leonardo Viana Nicacio, Salvatore Antonio Pignata, Mansoor Raza Mirza, A. Sadozye, F. Forget, Krishnansu S. Tewari, C. Mondrup Andreassen, B. Melichar, David M. O'Malley, D. Collins, Ignace Vergote, Roisin E. O'Cearbhaill, Christine Gennigens
Publikováno v:
Annals of Oncology. 32:S726-S727
Autor:
Teresa Amaral, Miriam O'Connor, Kevin Punie, J.B.A.G. Haanen, Gilberto Morgan, Matteo Lambertini, K. Murali, Kok Haw Jonathan Lim, Elena Elez, Susana Banerjee, B. Devnani, Christoph B. Westphalen, Christoph Oing, Konstantinos Kamposioras, P. G. Lopez, Claire Hardy, E. Thorne
Publikováno v:
Annals of Oncology
Background: The ESMO Resilience Task Force has investigated wellbeing since COVID-19 in relation to work, lifestyle and support factors in oncology professionals globally. We reported on the significant impact of the initial surge of the pandemic on
Publikováno v:
Scientia
ESMO open, vol. 6, no. 3, pp. 100130
ESMO Open
Immuno-Oncology and Technology, Vol 9, Iss, Pp 100027-(2021)
ESMO open, vol. 6, no. 3, pp. 100130
ESMO Open
Immuno-Oncology and Technology, Vol 9, Iss, Pp 100027-(2021)
Homenatge; José Baselga Homenaje; José Baselga Tribute; José Baselga It is with deep sadness that ESMO has learnt of the death of Professor José Baselga, renowned for his outstanding contributions in advancing cancer science, treatment and care f
Autor:
Kedan Lin, B Mackowiak-Matejczyk, Erika Hamilton, Joyce F. Liu, Kathleen N. Moore, Daniel J. Maslyar, Amit M. Oza, Michael J. Birrer, Lemahieu, Peter Trask, YounJeong Choi, Eva Schuth, Susana Banerjee, Jurjees Hasan, Jim Marsters, Yulei Wang, Eric W. Humke, Alexandra Leary, J Pikiel, I.L. Ray-Coquard, Anjali Vaze
Publikováno v:
Annals of Oncology. 29:917-923
Background: Lifastuzumab vedotin (LIFA) is a humanized anti-NaPi2b monoclonal antibody conjugated to a potent antimitotic agent, monomethyl auristatin E, which inhibits cell division by blocking the polymerization of tubulin. This study is the first
Autor:
Matthew G Krebs, Udai Banerji, Muneeb Mahmud, Anna Minchom, R. Shinde, H. Badham, Christina Yap, Andra Curcean, Juanita Lopez, J.S. de Bono, R. Grochot, Nina Tunariu, Martin Little, Alison Turner, Mona Parmar, J.P. Lima, R. Rahman, Susana Banerjee
Publikováno v:
Annals of Oncology. 32:S728
Autor:
Anita Wolfer, Apostolos Sarivalasis, Anneke M. Westermann, A. Casado Herraez, Judith R. Kroep, R. Le Scodan, B. Lucas, M. Auvray-Kuentz, Georges Coukos, Fernanda G. Herrera, Denarda Dangaj, Lana E. Kandalaft, Petronella B. Ottevanger, Maureen Vanlancker, Corneel Coens, M. Romeo Marin, Ana Montes, Susana Banerjee
Publikováno v:
Annals of Oncology. 32:S1308
Autor:
K. Murali, Teresa Amaral, Gilberto Morgan, M. O'Connor, C. Benedikt Westphalen, Christoph Oing, Matteo Lambertini, B. Devnani, Claire Hardy, Konstantinos Kamposioras, P. Garrido Lopez, Kok Haw Jonathan Lim, J.B.A.G. Haanen, Kevin Punie, E. Thorne, Susana Banerjee
Publikováno v:
Annals of Oncology
Background: The impact of the COVID-19 (CV-19) pandemic on wellbeing has the potential for serious negative consequences on work, home life and patient care The ESMO Resilience Task Force collaboration set out to investigate wellbeing in oncology ove
Autor:
M. Ferguson, Patricia Roxburgh, Joohyuk Sohn, Susana Banerjee, K. Meyer, Stefan Zimmermann, L. Ottesen, Susan M. Domchek, J-W. Kim, Salomon M. Stemmer, D.O. Koralek, Helen K. Angell, David M. O'Malley, H. Gao, Benoit You, Richard T. Penson, S Bastian, L Opincar, Yvette Drew
Publikováno v:
Annals of Oncology. 31:S615-S616
Autor:
Emuella Flood, Nicoletta Colombo, Charlie Gourley, Elizabeth S. Lowe, Carol Aghajanian, William H. Bradley, Anne Floquet, Giovanni Scambia, Susana Banerjee, Ana Oaknin, Byung-Tae Kim, Robert Hettle, Alexandra Leary, P. DiSilvestro, Antonio González-Martín, Michael Friedlander, Alla Lisyanskaya, Kathleen N. Moore, Amit M. Oza, Gabe S. Sonke
Publikováno v:
Annals of Oncology. 30:v405-v406
Background In SOLO1 (NCT01844986; GOG-3004), maintenance olaparib significantly improved PFS vs placebo (HR 0.30; 95% CI 0.23–0.41; Moore et al. NEJM 2018) in patients with newly diagnosed advanced OC, a BRCA mutation and clinical complete or parti